 Daniel Frank
Concepts (826)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microbiota | 41 | 2024 | 730 | 5.640 |
Why?
| | Gastrointestinal Microbiome | 50 | 2026 | 768 | 5.270 |
Why?
| | Sinusitis | 17 | 2023 | 227 | 4.530 |
Why?
| | Rhinitis | 15 | 2022 | 169 | 4.510 |
Why?
| | Bacteria | 34 | 2023 | 766 | 3.210 |
Why?
| | RNA, Ribosomal, 16S | 49 | 2024 | 508 | 3.070 |
Why?
| | Metagenome | 15 | 2019 | 126 | 2.980 |
Why?
| | Paranasal Sinuses | 10 | 2023 | 81 | 2.210 |
Why?
| | Intestines | 15 | 2022 | 354 | 2.100 |
Why?
| | Dysbiosis | 18 | 2025 | 188 | 2.030 |
Why?
| | Otitis Media | 8 | 2025 | 182 | 1.970 |
Why?
| | Feces | 26 | 2026 | 496 | 1.880 |
Why?
| | Intestinal Mucosa | 21 | 2025 | 675 | 1.580 |
Why?
| | RNA, Bacterial | 12 | 2018 | 182 | 1.500 |
Why?
| | Nasal Polyps | 5 | 2021 | 59 | 1.380 |
Why?
| | Nose | 4 | 2018 | 67 | 1.330 |
Why?
| | Staphylococcus aureus | 6 | 2018 | 454 | 1.270 |
Why?
| | Nasal Cavity | 6 | 2023 | 61 | 1.220 |
Why?
| | Infant Nutritional Physiological Phenomena | 6 | 2026 | 159 | 1.170 |
Why?
| | Sequence Analysis, DNA | 17 | 2020 | 778 | 1.140 |
Why?
| | Ileum | 5 | 2020 | 112 | 1.140 |
Why?
| | Bacteremia | 6 | 2018 | 222 | 1.110 |
Why?
| | Phylogeny | 25 | 2020 | 917 | 1.070 |
Why?
| | Crohn Disease | 6 | 2020 | 260 | 1.060 |
Why?
| | Staphylococcal Infections | 5 | 2018 | 393 | 1.010 |
Why?
| | Gastrointestinal Tract | 7 | 2022 | 204 | 0.990 |
Why?
| | Chronic Disease | 17 | 2022 | 1812 | 0.930 |
Why?
| | Burns | 6 | 2026 | 374 | 0.880 |
Why?
| | Diet | 11 | 2026 | 1278 | 0.870 |
Why?
| | Nod2 Signaling Adaptor Protein | 4 | 2019 | 34 | 0.840 |
Why?
| | HIV Infections | 15 | 2025 | 3195 | 0.830 |
Why?
| | Bacterial Typing Techniques | 4 | 2015 | 40 | 0.830 |
Why?
| | Infant Food | 3 | 2026 | 69 | 0.800 |
Why?
| | Biodiversity | 13 | 2020 | 311 | 0.790 |
Why?
| | Corynebacterium Infections | 3 | 2022 | 43 | 0.790 |
Why?
| | Clostridium Infections | 4 | 2018 | 74 | 0.780 |
Why?
| | Colon | 9 | 2025 | 309 | 0.760 |
Why?
| | Humans | 142 | 2026 | 145785 | 0.760 |
Why?
| | Nasopharynx | 5 | 2024 | 72 | 0.760 |
Why?
| | Endoribonucleases | 8 | 2002 | 77 | 0.750 |
Why?
| | Breast Feeding | 7 | 2025 | 447 | 0.720 |
Why?
| | Otitis Media, Suppurative | 1 | 2022 | 4 | 0.720 |
Why?
| | Bacterial Infections | 3 | 2015 | 247 | 0.720 |
Why?
| | Cholesteatoma | 1 | 2022 | 10 | 0.720 |
Why?
| | Inflammation Mediators | 3 | 2023 | 507 | 0.700 |
Why?
| | Inflammatory Bowel Diseases | 7 | 2018 | 364 | 0.700 |
Why?
| | RNA, Catalytic | 7 | 2001 | 191 | 0.680 |
Why?
| | Database Management Systems | 2 | 2013 | 51 | 0.670 |
Why?
| | Male | 77 | 2026 | 73012 | 0.660 |
Why?
| | Drinking Water | 1 | 2022 | 90 | 0.650 |
Why?
| | Serine Peptidase Inhibitor Kazal-Type 5 | 1 | 2020 | 3 | 0.640 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.640 |
Why?
| | Molecular Sequence Data | 27 | 2015 | 2883 | 0.630 |
Why?
| | Inflammation | 13 | 2025 | 2885 | 0.630 |
Why?
| | Proton Pump Inhibitors | 2 | 2018 | 109 | 0.630 |
Why?
| | User-Computer Interface | 2 | 2013 | 165 | 0.620 |
Why?
| | Female | 84 | 2026 | 79045 | 0.620 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 143 | 0.590 |
Why?
| | Animals | 59 | 2026 | 38106 | 0.590 |
Why?
| | Software | 3 | 2021 | 680 | 0.590 |
Why?
| | Polymerase Chain Reaction | 10 | 2018 | 1043 | 0.590 |
Why?
| | Esomeprazole | 1 | 2018 | 7 | 0.570 |
Why?
| | HIV-1 | 8 | 2024 | 908 | 0.550 |
Why?
| | Sequence Analysis, RNA | 5 | 2020 | 442 | 0.540 |
Why?
| | Colitis, Ulcerative | 3 | 2020 | 148 | 0.540 |
Why?
| | RNA, Ribosomal | 8 | 2013 | 168 | 0.540 |
Why?
| | Adult | 48 | 2025 | 40882 | 0.530 |
Why?
| | Genes, rRNA | 3 | 2015 | 38 | 0.520 |
Why?
| | Iron | 3 | 2017 | 359 | 0.520 |
Why?
| | Mice | 32 | 2026 | 18358 | 0.510 |
Why?
| | Fatty Liver | 2 | 2021 | 253 | 0.500 |
Why?
| | Middle Aged | 41 | 2025 | 36309 | 0.490 |
Why?
| | Arthritis, Experimental | 3 | 2024 | 136 | 0.490 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 561 | 0.490 |
Why?
| | Vagina | 5 | 2016 | 203 | 0.480 |
Why?
| | Membrane Proteins | 3 | 2021 | 1166 | 0.480 |
Why?
| | Butyrates | 3 | 2024 | 66 | 0.480 |
Why?
| | Pharynx | 1 | 2016 | 59 | 0.480 |
Why?
| | Non-alcoholic Fatty Liver Disease | 4 | 2022 | 265 | 0.470 |
Why?
| | Nose Diseases | 1 | 2016 | 17 | 0.470 |
Why?
| | Fatigue Syndrome, Chronic | 1 | 2015 | 19 | 0.470 |
Why?
| | Base Sequence | 18 | 2015 | 2171 | 0.460 |
Why?
| | Case-Control Studies | 15 | 2020 | 3634 | 0.460 |
Why?
| | Biofilms | 5 | 2016 | 292 | 0.450 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 160 | 0.440 |
Why?
| | Food | 2 | 2020 | 150 | 0.440 |
Why?
| | Molecular Epidemiology | 1 | 2015 | 74 | 0.430 |
Why?
| | Cross-Sectional Studies | 16 | 2023 | 5925 | 0.430 |
Why?
| | Immunity, Innate | 4 | 2019 | 835 | 0.430 |
Why?
| | Endotoxemia | 2 | 2014 | 86 | 0.430 |
Why?
| | Bacterial Translocation | 6 | 2026 | 52 | 0.420 |
Why?
| | Mice, Inbred C57BL | 18 | 2026 | 5995 | 0.410 |
Why?
| | Genome, Bacterial | 4 | 2016 | 123 | 0.410 |
Why?
| | Whole Genome Sequencing | 1 | 2015 | 178 | 0.410 |
Why?
| | Gram-Positive Bacteria | 1 | 2013 | 48 | 0.400 |
Why?
| | Computer Graphics | 1 | 2013 | 41 | 0.390 |
Why?
| | Lactobacillus | 4 | 2022 | 28 | 0.390 |
Why?
| | Escherichia coli Proteins | 5 | 2016 | 201 | 0.380 |
Why?
| | Host-Pathogen Interactions | 3 | 2011 | 361 | 0.380 |
Why?
| | Immunity, Mucosal | 4 | 2018 | 98 | 0.380 |
Why?
| | Iron, Dietary | 1 | 2013 | 23 | 0.380 |
Why?
| | Immunoglobulin A | 4 | 2022 | 214 | 0.380 |
Why?
| | Hippocampus | 1 | 2018 | 973 | 0.380 |
Why?
| | Lipid Metabolism | 2 | 2020 | 529 | 0.370 |
Why?
| | Ear, Middle | 6 | 2025 | 84 | 0.370 |
Why?
| | Smoking | 2 | 2020 | 1477 | 0.370 |
Why?
| | Bacterial Load | 1 | 2012 | 67 | 0.370 |
Why?
| | Liver | 4 | 2020 | 1899 | 0.360 |
Why?
| | Colitis | 4 | 2025 | 281 | 0.360 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 251 | 0.360 |
Why?
| | Genitalia, Female | 1 | 2012 | 42 | 0.360 |
Why?
| | Asthma | 2 | 2015 | 1797 | 0.350 |
Why?
| | Probiotics | 5 | 2018 | 61 | 0.350 |
Why?
| | Diet, High-Fat | 3 | 2019 | 266 | 0.350 |
Why?
| | Gastrointestinal Diseases | 3 | 2017 | 222 | 0.350 |
Why?
| | Ethanol | 3 | 2026 | 631 | 0.340 |
Why?
| | Genomics | 5 | 2020 | 830 | 0.330 |
Why?
| | Infant | 19 | 2026 | 10091 | 0.330 |
Why?
| | Livestock | 1 | 2010 | 9 | 0.330 |
Why?
| | Anti-Bacterial Agents | 9 | 2022 | 1925 | 0.330 |
Why?
| | Alcohol Drinking | 3 | 2024 | 843 | 0.320 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2012 | 440 | 0.320 |
Why?
| | Ribonucleoproteins, Small Nuclear | 4 | 1995 | 23 | 0.320 |
Why?
| | Isosorbide Dinitrate | 1 | 2010 | 3 | 0.320 |
Why?
| | Hydralazine | 1 | 2010 | 6 | 0.320 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2012 | 194 | 0.310 |
Why?
| | Antibodies, Fungal | 1 | 2010 | 11 | 0.310 |
Why?
| | DNA Primers | 3 | 2009 | 505 | 0.310 |
Why?
| | Fucosyltransferases | 2 | 2022 | 33 | 0.310 |
Why?
| | Obesity | 7 | 2023 | 3118 | 0.310 |
Why?
| | Stress, Psychological | 1 | 2018 | 1151 | 0.310 |
Why?
| | Cryptococcus neoformans | 1 | 2010 | 21 | 0.310 |
Why?
| | Fatty Acids, Volatile | 6 | 2024 | 60 | 0.310 |
Why?
| | Computational Biology | 3 | 2019 | 669 | 0.310 |
Why?
| | Escherichia coli | 9 | 2017 | 835 | 0.310 |
Why?
| | Agriculture | 1 | 2010 | 94 | 0.300 |
Why?
| | Alcohol-Related Disorders | 2 | 2008 | 121 | 0.300 |
Why?
| | Fluoroquinolones | 1 | 2009 | 44 | 0.300 |
Why?
| | Genome | 2 | 2009 | 305 | 0.300 |
Why?
| | Catheterization | 2 | 2009 | 184 | 0.300 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4568 | 0.300 |
Why?
| | Weight Loss | 3 | 2021 | 859 | 0.290 |
Why?
| | RNA, Small Nuclear | 3 | 1994 | 40 | 0.290 |
Why?
| | Corynebacterium | 4 | 2022 | 50 | 0.280 |
Why?
| | Mycobacterium avium subsp. paratuberculosis | 1 | 2008 | 3 | 0.280 |
Why?
| | Pancreatitis-Associated Proteins | 2 | 2025 | 12 | 0.280 |
Why?
| | Arthritis, Rheumatoid | 3 | 2023 | 1180 | 0.280 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 858 | 0.270 |
Why?
| | Behavior Therapy | 2 | 2021 | 296 | 0.270 |
Why?
| | Salmon | 2 | 2025 | 21 | 0.270 |
Why?
| | Wound Infection | 1 | 2009 | 60 | 0.270 |
Why?
| | Seafood | 2 | 2025 | 25 | 0.270 |
Why?
| | Aged | 19 | 2023 | 26217 | 0.270 |
Why?
| | Confidentiality | 1 | 2008 | 80 | 0.270 |
Why?
| | Intraepithelial Lymphocytes | 2 | 2018 | 17 | 0.270 |
Why?
| | DNA, Bacterial | 6 | 2017 | 320 | 0.270 |
Why?
| | Pedigree | 4 | 2025 | 515 | 0.260 |
Why?
| | Polycystic Ovary Syndrome | 2 | 2021 | 188 | 0.260 |
Why?
| | Milk, Human | 4 | 2023 | 175 | 0.260 |
Why?
| | Transcriptome | 5 | 2021 | 1042 | 0.260 |
Why?
| | Eukaryotic Cells | 3 | 2007 | 35 | 0.260 |
Why?
| | Physicians, Primary Care | 1 | 2010 | 208 | 0.260 |
Why?
| | Diabetes, Gestational | 2 | 2022 | 306 | 0.260 |
Why?
| | Video Recording | 1 | 2008 | 219 | 0.260 |
Why?
| | Genes, Bacterial | 5 | 2018 | 152 | 0.250 |
Why?
| | Pneumonia | 2 | 2025 | 636 | 0.250 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 92 | 0.250 |
Why?
| | Congresses as Topic | 1 | 2008 | 224 | 0.250 |
Why?
| | RNA, Transfer | 3 | 1998 | 143 | 0.250 |
Why?
| | Perilipin-2 | 2 | 2017 | 40 | 0.240 |
Why?
| | Fast Foods | 1 | 2026 | 21 | 0.240 |
Why?
| | Nucleic Acid Conformation | 7 | 2002 | 724 | 0.240 |
Why?
| | Homeostasis | 5 | 2020 | 644 | 0.240 |
Why?
| | Dietary Sugars | 1 | 2026 | 21 | 0.240 |
Why?
| | Genotype | 4 | 2019 | 1857 | 0.240 |
Why?
| | Carrier Proteins | 1 | 2010 | 729 | 0.240 |
Why?
| | Sodium, Dietary | 1 | 2026 | 42 | 0.240 |
Why?
| | Genetic Background | 1 | 2026 | 16 | 0.240 |
Why?
| | Anemia, Iron-Deficiency | 2 | 2017 | 62 | 0.240 |
Why?
| | Weaning | 1 | 2026 | 51 | 0.240 |
Why?
| | DNA, Ribosomal | 7 | 2017 | 84 | 0.230 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1133 | 0.230 |
Why?
| | Dietary Supplements | 3 | 2019 | 584 | 0.230 |
Why?
| | Child Development | 2 | 2026 | 483 | 0.230 |
Why?
| | Diabetes Mellitus, Type 1 | 7 | 2017 | 3937 | 0.230 |
Why?
| | Oxycodone | 1 | 2026 | 52 | 0.230 |
Why?
| | RNA Processing, Post-Transcriptional | 2 | 1998 | 90 | 0.230 |
Why?
| | Blueberry Plants | 1 | 2025 | 8 | 0.230 |
Why?
| | Genetic Predisposition to Disease | 3 | 2025 | 2399 | 0.230 |
Why?
| | Biomarkers | 10 | 2025 | 4302 | 0.230 |
Why?
| | Diet, Western | 3 | 2022 | 88 | 0.220 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.220 |
Why?
| | Public Health | 1 | 2010 | 574 | 0.220 |
Why?
| | Research | 1 | 2008 | 431 | 0.220 |
Why?
| | Phenotype | 8 | 2020 | 3170 | 0.220 |
Why?
| | Mice, Inbred NOD | 4 | 2022 | 616 | 0.220 |
Why?
| | Physician-Patient Relations | 1 | 2010 | 588 | 0.220 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2025 | 38 | 0.210 |
Why?
| | Bile Acids and Salts | 3 | 2022 | 163 | 0.210 |
Why?
| | Attitude of Health Personnel | 2 | 2010 | 1197 | 0.210 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2017 | 534 | 0.210 |
Why?
| | Blood-Brain Barrier | 1 | 2026 | 160 | 0.210 |
Why?
| | Pentanols | 1 | 2024 | 6 | 0.210 |
Why?
| | Construction Materials | 2 | 2015 | 18 | 0.210 |
Why?
| | Neoplasms | 2 | 2018 | 2913 | 0.210 |
Why?
| | Alcoholic Intoxication | 1 | 2025 | 76 | 0.210 |
Why?
| | Streptococcus pneumoniae | 2 | 2024 | 186 | 0.210 |
Why?
| | Palatine Tonsil | 1 | 2024 | 54 | 0.210 |
Why?
| | Lyases | 1 | 2024 | 15 | 0.210 |
Why?
| | Air Microbiology | 2 | 2015 | 37 | 0.210 |
Why?
| | Autism Spectrum Disorder | 2 | 2023 | 423 | 0.210 |
Why?
| | Th17 Cells | 1 | 2025 | 102 | 0.210 |
Why?
| | Cohort Studies | 7 | 2022 | 6033 | 0.210 |
Why?
| | Infant Formula | 2 | 2023 | 71 | 0.200 |
Why?
| | Glycerophospholipids | 1 | 2024 | 39 | 0.200 |
Why?
| | Pneumococcal Infections | 1 | 2024 | 104 | 0.200 |
Why?
| | Adolescent | 14 | 2024 | 22577 | 0.200 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 172 | 0.200 |
Why?
| | Diet, Mediterranean | 1 | 2023 | 27 | 0.200 |
Why?
| | Young Adult | 13 | 2024 | 14254 | 0.190 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 101 | 0.190 |
Why?
| | Pregnancy | 11 | 2025 | 7216 | 0.190 |
Why?
| | RNA, Fungal | 5 | 2002 | 67 | 0.190 |
Why?
| | RNA Splicing | 3 | 1995 | 284 | 0.190 |
Why?
| | Ear Canal | 1 | 2003 | 14 | 0.190 |
Why?
| | Species Specificity | 4 | 2020 | 546 | 0.190 |
Why?
| | Ribonuclease P | 7 | 2001 | 22 | 0.190 |
Why?
| | Alternative Splicing | 1 | 2025 | 248 | 0.180 |
Why?
| | Disease Susceptibility | 3 | 2020 | 344 | 0.180 |
Why?
| | Gene Ontology | 1 | 2022 | 54 | 0.180 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.180 |
Why?
| | Mycobacterium | 1 | 2023 | 101 | 0.180 |
Why?
| | Fungal Proteins | 2 | 2000 | 143 | 0.180 |
Why?
| | Genetic Variation | 4 | 2018 | 977 | 0.180 |
Why?
| | Hypersensitivity | 1 | 2025 | 254 | 0.180 |
Why?
| | Mice, Knockout | 6 | 2025 | 3130 | 0.180 |
Why?
| | Sepsis | 2 | 2023 | 664 | 0.180 |
Why?
| | Olfaction Disorders | 1 | 2023 | 70 | 0.180 |
Why?
| | Mass Screening | 2 | 2008 | 1361 | 0.180 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2022 | 9 | 0.180 |
Why?
| | Micronutrients | 2 | 2026 | 102 | 0.180 |
Why?
| | Exome | 2 | 2020 | 229 | 0.180 |
Why?
| | Immunity | 2 | 2014 | 140 | 0.170 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 110 | 0.170 |
Why?
| | Anti-Inflammatory Agents | 2 | 2016 | 478 | 0.170 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 411 | 0.170 |
Why?
| | Cadherin Related Proteins | 1 | 2021 | 12 | 0.170 |
Why?
| | Haemophilus Infections | 1 | 2022 | 46 | 0.170 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 60 | 0.170 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2022 | 1146 | 0.170 |
Why?
| | Rats | 9 | 2026 | 5585 | 0.170 |
Why?
| | Child, Preschool | 10 | 2025 | 11868 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 231 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2012 | 199 | 0.170 |
Why?
| | Genes, Fungal | 4 | 2000 | 55 | 0.160 |
Why?
| | Toxins, Biological | 1 | 2020 | 12 | 0.160 |
Why?
| | Child | 12 | 2025 | 22740 | 0.160 |
Why?
| | Nutritional Status | 2 | 2014 | 353 | 0.160 |
Why?
| | Health | 2 | 2012 | 82 | 0.160 |
Why?
| | Ascomycota | 1 | 2000 | 26 | 0.160 |
Why?
| | Ear, External | 1 | 2020 | 21 | 0.160 |
Why?
| | Plasminogen | 1 | 2020 | 27 | 0.160 |
Why?
| | Cecum | 4 | 2026 | 37 | 0.160 |
Why?
| | Mice, Nude | 1 | 2022 | 680 | 0.160 |
Why?
| | Islets of Langerhans | 3 | 2015 | 847 | 0.160 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 5 | 2002 | 574 | 0.160 |
Why?
| | Mucin 5AC | 1 | 2020 | 71 | 0.160 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 303 | 0.150 |
Why?
| | Mouth | 1 | 2020 | 86 | 0.150 |
Why?
| | Pore Forming Cytotoxic Proteins | 1 | 2020 | 15 | 0.150 |
Why?
| | Carcinogenesis | 1 | 2022 | 228 | 0.150 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.150 |
Why?
| | Body Mass Index | 5 | 2020 | 2447 | 0.150 |
Why?
| | Tobacco Smoke Pollution | 1 | 2022 | 227 | 0.150 |
Why?
| | Aged, 80 and over | 6 | 2021 | 8347 | 0.150 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 140 | 0.150 |
Why?
| | Bacteroides | 1 | 2019 | 20 | 0.150 |
Why?
| | Corrinoids | 1 | 2019 | 7 | 0.150 |
Why?
| | Vascular Remodeling | 1 | 2021 | 209 | 0.150 |
Why?
| | Chemoreceptor Cells | 1 | 2019 | 50 | 0.150 |
Why?
| | Double-Blind Method | 4 | 2025 | 2064 | 0.150 |
Why?
| | Autoimmunity | 3 | 2015 | 933 | 0.150 |
Why?
| | X-Box Binding Protein 1 | 1 | 2019 | 16 | 0.150 |
Why?
| | Vitamin B Complex | 1 | 2019 | 39 | 0.140 |
Why?
| | Infant, Newborn | 5 | 2025 | 6465 | 0.140 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 339 | 0.140 |
Why?
| | Surveys and Questionnaires | 3 | 2009 | 6085 | 0.140 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2020 | 178 | 0.140 |
Why?
| | Organic Chemicals | 1 | 2020 | 112 | 0.140 |
Why?
| | Restraint, Physical | 1 | 2018 | 75 | 0.140 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2020 | 2181 | 0.140 |
Why?
| | Oxonic Acid | 1 | 2018 | 13 | 0.140 |
Why?
| | Nutritive Value | 2 | 2026 | 41 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 335 | 0.140 |
Why?
| | Microbiological Techniques | 2 | 2016 | 30 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2018 | 47 | 0.140 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2191 | 0.140 |
Why?
| | Corrosion | 2 | 2015 | 16 | 0.140 |
Why?
| | Vitamin B 12 | 1 | 2019 | 135 | 0.140 |
Why?
| | Colony Count, Microbial | 3 | 2016 | 89 | 0.130 |
Why?
| | Evolution, Molecular | 2 | 2018 | 494 | 0.130 |
Why?
| | Digestive System Surgical Procedures | 1 | 2019 | 112 | 0.130 |
Why?
| | Random Allocation | 1 | 2018 | 365 | 0.130 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2018 | 27 | 0.130 |
Why?
| | Immunoglobulin D | 1 | 2017 | 29 | 0.130 |
Why?
| | Bacteroidaceae | 1 | 2017 | 3 | 0.130 |
Why?
| | Respiratory Sounds | 1 | 2018 | 103 | 0.130 |
Why?
| | Citrobacter rodentium | 1 | 2017 | 6 | 0.130 |
Why?
| | Spondylarthritis | 1 | 2018 | 50 | 0.130 |
Why?
| | Cytokines | 5 | 2025 | 2069 | 0.130 |
Why?
| | Meta-Analysis as Topic | 2 | 2008 | 173 | 0.130 |
Why?
| | Birth Weight | 1 | 2020 | 517 | 0.130 |
Why?
| | Bacterial Toxins | 1 | 2018 | 108 | 0.130 |
Why?
| | Analgesics, Opioid | 1 | 2026 | 1154 | 0.130 |
Why?
| | Enterobacteriaceae Infections | 1 | 2017 | 42 | 0.130 |
Why?
| | Lung | 4 | 2022 | 4116 | 0.130 |
Why?
| | Parvovirus | 2 | 2017 | 13 | 0.130 |
Why?
| | Water Microbiology | 3 | 2016 | 85 | 0.130 |
Why?
| | Prospective Studies | 4 | 2020 | 8078 | 0.120 |
Why?
| | Myeloid Differentiation Factor 88 | 2 | 2017 | 119 | 0.120 |
Why?
| | Ceftriaxone | 1 | 2016 | 21 | 0.120 |
Why?
| | Autoantibodies | 3 | 2022 | 1509 | 0.120 |
Why?
| | Gene Expression | 2 | 2018 | 1478 | 0.120 |
Why?
| | Metals | 1 | 1997 | 136 | 0.120 |
Why?
| | beta-Lactamases | 1 | 2016 | 53 | 0.120 |
Why?
| | Pelvic Infection | 1 | 2016 | 6 | 0.120 |
Why?
| | Down Syndrome | 1 | 2023 | 525 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2020 | 361 | 0.120 |
Why?
| | Vaccines, Inactivated | 1 | 2016 | 70 | 0.120 |
Why?
| | Metabolome | 1 | 2020 | 391 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 615 | 0.120 |
Why?
| | Tissue Adhesives | 1 | 2016 | 21 | 0.120 |
Why?
| | Oligonucleotide Probes | 3 | 2005 | 48 | 0.120 |
Why?
| | Salmonella Infections | 1 | 2016 | 57 | 0.120 |
Why?
| | Vitamin E | 1 | 2016 | 125 | 0.120 |
Why?
| | Bacillus | 1 | 2015 | 17 | 0.120 |
Why?
| | Binding Sites | 6 | 1998 | 1311 | 0.120 |
Why?
| | Cholesterol | 3 | 2023 | 408 | 0.120 |
Why?
| | Symbiosis | 2 | 2017 | 72 | 0.120 |
Why?
| | Ethmoid Sinus | 1 | 2015 | 6 | 0.120 |
Why?
| | Vaccines, Attenuated | 1 | 2016 | 129 | 0.120 |
Why?
| | Therapeutic Irrigation | 1 | 2016 | 68 | 0.120 |
Why?
| | Antibiosis | 1 | 2015 | 10 | 0.110 |
Why?
| | Streptococcus mitis | 1 | 2015 | 10 | 0.110 |
Why?
| | Gelatin | 1 | 2016 | 56 | 0.110 |
Why?
| | Metagenomics | 2 | 2019 | 150 | 0.110 |
Why?
| | Textiles | 1 | 2015 | 22 | 0.110 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 47 | 0.110 |
Why?
| | Interleukin-6 | 2 | 2017 | 780 | 0.110 |
Why?
| | RNA, Messenger | 4 | 2018 | 2805 | 0.110 |
Why?
| | Rhinitis, Allergic | 1 | 2016 | 42 | 0.110 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2015 | 20 | 0.110 |
Why?
| | Lymph | 1 | 2015 | 31 | 0.110 |
Why?
| | Electrophoresis, Gel, Pulsed-Field | 1 | 2015 | 22 | 0.110 |
Why?
| | Dietary Fats | 1 | 2017 | 308 | 0.110 |
Why?
| | Catalase | 1 | 2015 | 134 | 0.110 |
Why?
| | Sanitary Engineering | 1 | 2015 | 5 | 0.110 |
Why?
| | Thrombophilia | 1 | 2016 | 89 | 0.110 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 59 | 0.110 |
Why?
| | Diet, Fat-Restricted | 1 | 2015 | 79 | 0.110 |
Why?
| | Hysterectomy | 1 | 2016 | 138 | 0.110 |
Why?
| | Bacteriology | 1 | 2014 | 3 | 0.110 |
Why?
| | Rectum | 1 | 2016 | 182 | 0.110 |
Why?
| | Thrombin | 1 | 2016 | 172 | 0.110 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2015 | 40 | 0.110 |
Why?
| | Health Facilities | 1 | 2015 | 85 | 0.110 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 159 | 0.110 |
Why?
| | Salmonella typhimurium | 1 | 2016 | 188 | 0.110 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 279 | 0.110 |
Why?
| | Carrier State | 1 | 2015 | 78 | 0.110 |
Why?
| | Hospitalization | 3 | 2018 | 2461 | 0.110 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 95 | 0.110 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2123 | 0.110 |
Why?
| | Soil Microbiology | 1 | 2015 | 115 | 0.110 |
Why?
| | Siblings | 1 | 2015 | 196 | 0.110 |
Why?
| | Household Articles | 1 | 2014 | 28 | 0.110 |
Why?
| | Bacterial Adhesion | 1 | 2015 | 109 | 0.110 |
Why?
| | Physical Exertion | 1 | 2015 | 205 | 0.110 |
Why?
| | Humidity | 1 | 2014 | 49 | 0.110 |
Why?
| | Gentamicins | 1 | 2015 | 50 | 0.110 |
Why?
| | Escherichia coli Infections | 1 | 2015 | 125 | 0.110 |
Why?
| | Leptin | 1 | 2016 | 248 | 0.110 |
Why?
| | Adiposity | 2 | 2018 | 532 | 0.100 |
Why?
| | Biota | 1 | 2014 | 29 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 920 | 0.100 |
Why?
| | Mucous Membrane | 1 | 2015 | 128 | 0.100 |
Why?
| | Genetics, Medical | 2 | 2011 | 23 | 0.100 |
Why?
| | Bifidobacterium | 3 | 2022 | 21 | 0.100 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 1994 | 11 | 0.100 |
Why?
| | Maternal Welfare | 1 | 2014 | 22 | 0.100 |
Why?
| | Antibiotic Prophylaxis | 1 | 2015 | 134 | 0.100 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 129 | 0.100 |
Why?
| | Diabetes Mellitus | 2 | 2013 | 1101 | 0.100 |
Why?
| | Body Weight | 2 | 2015 | 972 | 0.100 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2020 | 655 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 979 | 0.100 |
Why?
| | Toll-Like Receptor 3 | 1 | 2013 | 30 | 0.100 |
Why?
| | Hydrogen Sulfide | 1 | 2014 | 47 | 0.100 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2020 | 668 | 0.100 |
Why?
| | Hypoxia | 1 | 2021 | 1199 | 0.100 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2014 | 55 | 0.100 |
Why?
| | Consensus | 1 | 2016 | 479 | 0.100 |
Why?
| | Nutrition Assessment | 1 | 2014 | 90 | 0.100 |
Why?
| | Preconception Care | 1 | 2014 | 50 | 0.100 |
Why?
| | Longitudinal Studies | 3 | 2026 | 2968 | 0.100 |
Why?
| | Railroads | 1 | 2013 | 6 | 0.100 |
Why?
| | Bacteroidetes | 3 | 2021 | 21 | 0.100 |
Why?
| | Energy Intake | 2 | 2026 | 512 | 0.100 |
Why?
| | Haemophilus influenzae | 2 | 2025 | 68 | 0.090 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 199 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 868 | 0.090 |
Why?
| | Antioxidants | 1 | 2016 | 550 | 0.090 |
Why?
| | Gastric Bypass | 1 | 2014 | 126 | 0.090 |
Why?
| | Zinc Fingers | 1 | 1992 | 50 | 0.090 |
Why?
| | Burkina Faso | 1 | 2012 | 7 | 0.090 |
Why?
| | Pediatric Obesity | 1 | 2020 | 638 | 0.090 |
Why?
| | Carbon Dioxide | 1 | 2014 | 227 | 0.090 |
Why?
| | Drug Combinations | 2 | 2012 | 396 | 0.090 |
Why?
| | Aerosols | 1 | 2013 | 146 | 0.090 |
Why?
| | Paneth Cells | 1 | 2012 | 20 | 0.090 |
Why?
| | Xenobiotics | 1 | 2012 | 30 | 0.090 |
Why?
| | Antibodies, Viral | 1 | 2016 | 674 | 0.090 |
Why?
| | Mammary Glands, Human | 1 | 2012 | 68 | 0.090 |
Why?
| | Evidence-Based Medicine | 1 | 2016 | 740 | 0.090 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 484 | 0.090 |
Why?
| | Influenza Vaccines | 1 | 2016 | 534 | 0.090 |
Why?
| | Gonadal Steroid Hormones | 1 | 2013 | 143 | 0.090 |
Why?
| | Prenatal Care | 1 | 2014 | 309 | 0.090 |
Why?
| | Skin | 1 | 2016 | 754 | 0.080 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2012 | 751 | 0.080 |
Why?
| | Morphogenesis | 1 | 2012 | 171 | 0.080 |
Why?
| | Bacterial Proteins | 1 | 2018 | 968 | 0.080 |
Why?
| | Lactation | 1 | 2012 | 193 | 0.080 |
Why?
| | Food Safety | 1 | 2010 | 21 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1497 | 0.080 |
Why?
| | Autophagy-Related Proteins | 1 | 2010 | 46 | 0.080 |
Why?
| | Testosterone | 1 | 2014 | 416 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2014 | 293 | 0.080 |
Why?
| | Bacterial Capsules | 1 | 2010 | 33 | 0.080 |
Why?
| | Amphotericin B | 1 | 2010 | 36 | 0.080 |
Why?
| | Viruses | 1 | 2012 | 166 | 0.080 |
Why?
| | Hypertension, Pulmonary | 1 | 2021 | 1957 | 0.080 |
Why?
| | Meningitis, Cryptococcal | 1 | 2010 | 34 | 0.080 |
Why?
| | Staphylococcus epidermidis | 1 | 2010 | 79 | 0.080 |
Why?
| | Cluster Analysis | 3 | 2017 | 501 | 0.080 |
Why?
| | Dextran Sulfate | 2 | 2020 | 93 | 0.080 |
Why?
| | Insulin | 2 | 2022 | 2516 | 0.080 |
Why?
| | Urinary Catheterization | 1 | 2009 | 35 | 0.070 |
Why?
| | Risk Factors | 4 | 2018 | 10919 | 0.070 |
Why?
| | Biomass | 1 | 2009 | 96 | 0.070 |
Why?
| | Antibodies, Monoclonal | 2 | 2022 | 1505 | 0.070 |
Why?
| | Prostatectomy | 1 | 2009 | 94 | 0.070 |
Why?
| | Treatment Outcome | 5 | 2018 | 11794 | 0.070 |
Why?
| | Montana | 1 | 2009 | 18 | 0.070 |
Why?
| | Mississippi | 1 | 2009 | 28 | 0.070 |
Why?
| | Sequence Alignment | 3 | 2001 | 362 | 0.070 |
Why?
| | Catheters, Indwelling | 1 | 2009 | 96 | 0.070 |
Why?
| | Fatty Acids | 3 | 2022 | 457 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2017 | 1165 | 0.070 |
Why?
| | Prevalence | 2 | 2014 | 2875 | 0.070 |
Why?
| | Permeability | 2 | 2022 | 169 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 923 | 0.070 |
Why?
| | Oligodeoxyribonucleotides | 3 | 1994 | 141 | 0.070 |
Why?
| | Environment | 1 | 2010 | 293 | 0.070 |
Why?
| | Rats, Inbred Lew | 3 | 2017 | 105 | 0.070 |
Why?
| | Ecosystem | 2 | 2010 | 478 | 0.070 |
Why?
| | Systems Integration | 1 | 2008 | 36 | 0.070 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 319 | 0.070 |
Why?
| | Models, Statistical | 1 | 2013 | 672 | 0.070 |
Why?
| | Housing | 1 | 2009 | 142 | 0.070 |
Why?
| | Sensitivity and Specificity | 3 | 2008 | 2000 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2022 | 17330 | 0.070 |
Why?
| | Down-Regulation | 2 | 2024 | 618 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2015 | 2601 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2602 | 0.070 |
Why?
| | RNA Precursors | 4 | 1998 | 154 | 0.070 |
Why?
| | Gram-Negative Bacteria | 2 | 2004 | 80 | 0.070 |
Why?
| | Geologic Sediments | 1 | 2007 | 46 | 0.070 |
Why?
| | Information Storage and Retrieval | 1 | 2008 | 123 | 0.060 |
Why?
| | Physicians, Family | 1 | 2009 | 177 | 0.060 |
Why?
| | Prognosis | 2 | 2020 | 4330 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2013 | 789 | 0.060 |
Why?
| | Urinary Tract Infections | 1 | 2009 | 210 | 0.060 |
Why?
| | Plasmids | 4 | 2016 | 373 | 0.060 |
Why?
| | Focus Groups | 1 | 2010 | 572 | 0.060 |
Why?
| | Residence Characteristics | 1 | 2010 | 375 | 0.060 |
Why?
| | Cross Infection | 1 | 2009 | 260 | 0.060 |
Why?
| | Pseudomonas Infections | 1 | 2009 | 231 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2023 | 3418 | 0.060 |
Why?
| | Indomethacin | 1 | 2006 | 76 | 0.060 |
Why?
| | Peptic Ulcer | 1 | 2006 | 18 | 0.060 |
Why?
| | Research Personnel | 1 | 2008 | 185 | 0.060 |
Why?
| | Enterococcus faecalis | 1 | 2006 | 29 | 0.060 |
Why?
| | Structure-Activity Relationship | 2 | 2000 | 563 | 0.060 |
Why?
| | Diet Records | 1 | 2026 | 89 | 0.060 |
Why?
| | Common Variable Immunodeficiency | 1 | 2006 | 26 | 0.060 |
Why?
| | Proteobacteria | 2 | 2017 | 16 | 0.060 |
Why?
| | Opportunistic Infections | 1 | 2006 | 47 | 0.060 |
Why?
| | Autoantigens | 2 | 2022 | 427 | 0.060 |
Why?
| | Kenya | 2 | 2017 | 129 | 0.060 |
Why?
| | Immunoglobulin G | 2 | 2022 | 892 | 0.060 |
Why?
| | Self Administration | 1 | 2026 | 122 | 0.060 |
Why?
| | Up-Regulation | 2 | 2021 | 848 | 0.060 |
Why?
| | Principal Component Analysis | 2 | 2017 | 194 | 0.060 |
Why?
| | Inpatients | 1 | 2010 | 553 | 0.060 |
Why?
| | Intestine, Small | 1 | 2006 | 167 | 0.060 |
Why?
| | Clostridium | 2 | 2017 | 19 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 19 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 56 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 33 | 0.060 |
Why?
| | Short Bowel Syndrome | 1 | 2005 | 27 | 0.050 |
Why?
| | Cloning, Molecular | 3 | 1996 | 538 | 0.050 |
Why?
| | Body Composition | 2 | 2021 | 693 | 0.050 |
Why?
| | Hexanols | 1 | 2024 | 7 | 0.050 |
Why?
| | Cystic Fibrosis | 1 | 2015 | 1163 | 0.050 |
Why?
| | Fruit | 1 | 2025 | 146 | 0.050 |
Why?
| | Oropharynx | 1 | 2024 | 46 | 0.050 |
Why?
| | Age Factors | 2 | 2025 | 3346 | 0.050 |
Why?
| | In Situ Hybridization | 1 | 2005 | 318 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2005 | 328 | 0.050 |
Why?
| | Mycobacterium avium Complex | 1 | 2005 | 87 | 0.050 |
Why?
| | Mice, Inbred DBA | 1 | 2024 | 182 | 0.050 |
Why?
| | Methylamines | 1 | 2024 | 39 | 0.050 |
Why?
| | Gram-Positive Bacterial Infections | 1 | 2005 | 72 | 0.050 |
Why?
| | Mycobacterium avium-intracellulare Infection | 1 | 2005 | 63 | 0.050 |
Why?
| | Metabolic Networks and Pathways | 2 | 2017 | 175 | 0.050 |
Why?
| | Hydrogen Bonding | 2 | 1994 | 169 | 0.050 |
Why?
| | Comorbidity | 1 | 2009 | 1662 | 0.050 |
Why?
| | Mycobacterium smegmatis | 1 | 2023 | 14 | 0.050 |
Why?
| | Blood Pressure | 2 | 2021 | 1782 | 0.050 |
Why?
| | Bites and Stings | 1 | 2004 | 30 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1217 | 0.050 |
Why?
| | Cellulitis | 1 | 2004 | 54 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 90 | 0.050 |
Why?
| | Zoonoses | 1 | 2004 | 39 | 0.050 |
Why?
| | Artificial Intelligence | 1 | 2008 | 381 | 0.050 |
Why?
| | Microglia | 1 | 2026 | 273 | 0.050 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 346 | 0.050 |
Why?
| | Cats | 1 | 2004 | 234 | 0.050 |
Why?
| | Choline | 1 | 2024 | 138 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2015 | 532 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 2525 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2023 | 120 | 0.050 |
Why?
| | Animal Husbandry | 1 | 2023 | 33 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 544 | 0.050 |
Why?
| | Gram-Negative Anaerobic Bacteria | 1 | 2002 | 2 | 0.050 |
Why?
| | Ammonia | 1 | 2023 | 61 | 0.050 |
Why?
| | Linear Models | 2 | 2016 | 849 | 0.050 |
Why?
| | alpha-Defensins | 1 | 2022 | 11 | 0.050 |
Why?
| | Sanitation | 1 | 2023 | 56 | 0.050 |
Why?
| | Housing, Animal | 1 | 2023 | 46 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 34 | 0.050 |
Why?
| | Chemokines | 1 | 2023 | 217 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 41 | 0.050 |
Why?
| | Fetal Death | 1 | 2002 | 58 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 182 | 0.050 |
Why?
| | Weight Gain | 1 | 2026 | 561 | 0.040 |
Why?
| | Pilot Projects | 2 | 2018 | 1898 | 0.040 |
Why?
| | Glycerol | 1 | 2022 | 90 | 0.040 |
Why?
| | Viral Load | 2 | 2015 | 526 | 0.040 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 318 | 0.040 |
Why?
| | Virulence | 1 | 2023 | 278 | 0.040 |
Why?
| | Smell | 1 | 2023 | 126 | 0.040 |
Why?
| | Amniotic Fluid | 1 | 2002 | 79 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1992 | 376 | 0.040 |
Why?
| | Granzymes | 1 | 2022 | 49 | 0.040 |
Why?
| | Multigene Family | 2 | 2012 | 210 | 0.040 |
Why?
| | Algorithms | 1 | 2009 | 1851 | 0.040 |
Why?
| | Japan | 1 | 2021 | 149 | 0.040 |
Why?
| | Immunity, Humoral | 1 | 2022 | 118 | 0.040 |
Why?
| | Ligands | 1 | 2023 | 668 | 0.040 |
Why?
| | Pigments, Biological | 1 | 2001 | 17 | 0.040 |
Why?
| | RNA, Archaeal | 1 | 2001 | 12 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 457 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 421 | 0.040 |
Why?
| | Systole | 1 | 2021 | 181 | 0.040 |
Why?
| | Diet, Reducing | 1 | 2021 | 91 | 0.040 |
Why?
| | Waist Circumference | 1 | 2021 | 143 | 0.040 |
Why?
| | Tight Junctions | 1 | 2021 | 82 | 0.040 |
Why?
| | Aerobiosis | 1 | 2020 | 18 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2021 | 149 | 0.040 |
Why?
| | Consensus Sequence | 1 | 2000 | 73 | 0.040 |
Why?
| | Macrophages | 2 | 2021 | 1507 | 0.040 |
Why?
| | Acetylation | 1 | 2021 | 259 | 0.040 |
Why?
| | Follow-Up Studies | 3 | 2020 | 5428 | 0.040 |
Why?
| | DNA, Fungal | 1 | 2000 | 76 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 440 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1723 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2024 | 396 | 0.040 |
Why?
| | Microvessels | 1 | 2021 | 97 | 0.040 |
Why?
| | Protective Factors | 1 | 2020 | 99 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2003 | 375 | 0.040 |
Why?
| | Abortion, Spontaneous | 1 | 2001 | 119 | 0.040 |
Why?
| | Caloric Restriction | 1 | 2021 | 133 | 0.040 |
Why?
| | Biotransformation | 1 | 2020 | 62 | 0.040 |
Why?
| | Fibrosis | 1 | 2022 | 561 | 0.040 |
Why?
| | Catalytic Domain | 1 | 2000 | 234 | 0.040 |
Why?
| | Fasting | 1 | 2021 | 279 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 112 | 0.040 |
Why?
| | Urinalysis | 1 | 2020 | 83 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2021 | 361 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 183 | 0.040 |
Why?
| | Catalysis | 2 | 1998 | 305 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2002 | 157 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2020 | 174 | 0.040 |
Why?
| | Mutation | 3 | 2021 | 4090 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 143 | 0.040 |
Why?
| | Time Factors | 1 | 2010 | 7134 | 0.040 |
Why?
| | Substrate Specificity | 2 | 1997 | 387 | 0.040 |
Why?
| | Germ-Free Life | 1 | 2018 | 33 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2020 | 135 | 0.040 |
Why?
| | Saliva | 1 | 2020 | 249 | 0.030 |
Why?
| | Cytoprotection | 1 | 2018 | 56 | 0.030 |
Why?
| | RNA, Transfer, Asp | 1 | 1998 | 3 | 0.030 |
Why?
| | Serine Endopeptidases | 2 | 1989 | 129 | 0.030 |
Why?
| | COS Cells | 1 | 2018 | 177 | 0.030 |
Why?
| | Collagen Type II | 1 | 2018 | 53 | 0.030 |
Why?
| | Lipids | 1 | 2023 | 707 | 0.030 |
Why?
| | HIV Seropositivity | 1 | 2019 | 119 | 0.030 |
Why?
| | Prokaryotic Cells | 1 | 1998 | 6 | 0.030 |
Why?
| | Acute Disease | 2 | 2016 | 1036 | 0.030 |
Why?
| | Magnesium | 1 | 1998 | 157 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2020 | 592 | 0.030 |
Why?
| | Syndecan-1 | 1 | 2017 | 43 | 0.030 |
Why?
| | Powders | 1 | 2017 | 44 | 0.030 |
Why?
| | Pancrelipase | 1 | 2017 | 6 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2020 | 610 | 0.030 |
Why?
| | Cell Membrane Permeability | 1 | 2017 | 88 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 167 | 0.030 |
Why?
| | Plasma Cells | 1 | 2017 | 80 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2018 | 450 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 474 | 0.030 |
Why?
| | Prophages | 1 | 2016 | 8 | 0.030 |
Why?
| | Mucus | 1 | 2017 | 75 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2020 | 1261 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1050 | 0.030 |
Why?
| | Hydroxamic Acids | 1 | 2017 | 94 | 0.030 |
Why?
| | Anthropometry | 1 | 2017 | 206 | 0.030 |
Why?
| | Genetic Complementation Test | 2 | 1995 | 72 | 0.030 |
Why?
| | United States | 3 | 2026 | 16126 | 0.030 |
Why?
| | Ciprofloxacin | 1 | 2016 | 31 | 0.030 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2016 | 38 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 5 | 0.030 |
Why?
| | Heart Failure | 1 | 2010 | 2326 | 0.030 |
Why?
| | Heart Ventricles | 1 | 2021 | 756 | 0.030 |
Why?
| | Gene Library | 1 | 1996 | 122 | 0.030 |
Why?
| | Ferritins | 1 | 2016 | 70 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 867 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 13 | 0.030 |
Why?
| | Primary Health Care | 1 | 2007 | 1737 | 0.030 |
Why?
| | Interleukin-8 | 1 | 2017 | 269 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 265 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 25 | 0.030 |
Why?
| | Enzyme Activation | 1 | 1997 | 762 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 29 | 0.030 |
Why?
| | Rifamycins | 1 | 2016 | 6 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2933 | 0.030 |
Why?
| | Sulfasalazine | 1 | 2016 | 22 | 0.030 |
Why?
| | Macaca nemestrina | 1 | 2016 | 29 | 0.030 |
Why?
| | Zebrafish | 1 | 2000 | 532 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2018 | 741 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.030 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 253 | 0.030 |
Why?
| | Equipment Contamination | 1 | 2016 | 67 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 182 | 0.030 |
Why?
| | Treatment Failure | 1 | 2016 | 360 | 0.030 |
Why?
| | North America | 1 | 2016 | 304 | 0.030 |
Why?
| | Alarmins | 1 | 2015 | 27 | 0.030 |
Why?
| | Mesentery | 1 | 2015 | 44 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 8 | 0.030 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2016 | 93 | 0.030 |
Why?
| | Capsule Endoscopes | 1 | 2015 | 7 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 365 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 26 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 645 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2021 | 878 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 60 | 0.030 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2015 | 41 | 0.030 |
Why?
| | Verrucomicrobia | 1 | 2014 | 4 | 0.030 |
Why?
| | Spleen | 1 | 2017 | 508 | 0.030 |
Why?
| | Molecular Typing | 1 | 2014 | 21 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 163 | 0.030 |
Why?
| | Bacterial Shedding | 1 | 2014 | 3 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 90 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1139 | 0.030 |
Why?
| | snRNP Core Proteins | 1 | 1994 | 4 | 0.030 |
Why?
| | Democratic Republic of the Congo | 1 | 2014 | 33 | 0.030 |
Why?
| | DNA, Recombinant | 1 | 1994 | 48 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 420 | 0.030 |
Why?
| | Methane | 1 | 2014 | 45 | 0.030 |
Why?
| | Porosity | 1 | 2014 | 94 | 0.030 |
Why?
| | Pakistan | 1 | 2014 | 79 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2017 | 509 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2028 | 0.030 |
Why?
| | Metabolomics | 1 | 2020 | 733 | 0.030 |
Why?
| | Models, Genetic | 2 | 1995 | 527 | 0.030 |
Why?
| | Poly I-C | 1 | 2013 | 58 | 0.030 |
Why?
| | Geography | 1 | 2014 | 187 | 0.020 |
Why?
| | Toll-Like Receptor 9 | 1 | 2013 | 37 | 0.020 |
Why?
| | Models, Animal | 1 | 2015 | 392 | 0.020 |
Why?
| | Antibodies, Neutralizing | 1 | 2016 | 340 | 0.020 |
Why?
| | Observer Variation | 1 | 2014 | 357 | 0.020 |
Why?
| | Oncogene Protein v-akt | 1 | 2013 | 24 | 0.020 |
Why?
| | Brain | 1 | 2026 | 2969 | 0.020 |
Why?
| | Sequence Deletion | 1 | 1994 | 191 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 263 | 0.020 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 280 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 2013 | 396 | 0.020 |
Why?
| | New York City | 1 | 2013 | 85 | 0.020 |
Why?
| | Cell Lineage | 1 | 2015 | 378 | 0.020 |
Why?
| | Glycoproteins | 1 | 2015 | 354 | 0.020 |
Why?
| | Seasons | 1 | 2015 | 538 | 0.020 |
Why?
| | Cell Line | 1 | 2018 | 2823 | 0.020 |
Why?
| | Genes, Synthetic | 1 | 1992 | 13 | 0.020 |
Why?
| | Diarrhea | 1 | 2014 | 193 | 0.020 |
Why?
| | Perioperative Care | 1 | 2015 | 231 | 0.020 |
Why?
| | Genes, Lethal | 1 | 1992 | 30 | 0.020 |
Why?
| | Trimethoprim | 1 | 2012 | 7 | 0.020 |
Why?
| | Sulfadoxine | 1 | 2012 | 4 | 0.020 |
Why?
| | Sulfamethoxazole | 1 | 2012 | 7 | 0.020 |
Why?
| | Peyer's Patches | 1 | 2012 | 7 | 0.020 |
Why?
| | Cattle | 2 | 2005 | 946 | 0.020 |
Why?
| | Staphylococcus | 1 | 2013 | 74 | 0.020 |
Why?
| | Endoscopy | 1 | 2015 | 317 | 0.020 |
Why?
| | Peritonitis | 1 | 2013 | 83 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2012 | 321 | 0.020 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 288 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 337 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1547 | 0.020 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 499 | 0.020 |
Why?
| | Mothers | 1 | 2018 | 766 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1973 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2013 | 193 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 51 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 428 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 2015 | 329 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1992 | 387 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 106 | 0.020 |
Why?
| | Antigens, CD | 1 | 2015 | 558 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2865 | 0.020 |
Why?
| | Milk | 1 | 2012 | 119 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1995 | 414 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 784 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1995 | 447 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1361 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 5226 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 501 | 0.020 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 128 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 420 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 1995 | 630 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 699 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2012 | 114 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 440 | 0.020 |
Why?
| | Databases, Genetic | 1 | 2012 | 238 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1184 | 0.020 |
Why?
| | Hospitals | 1 | 2015 | 733 | 0.020 |
Why?
| | Risk Assessment | 2 | 2014 | 3752 | 0.020 |
Why?
| | Blood Glucose | 1 | 2021 | 2344 | 0.020 |
Why?
| | Gestational Age | 1 | 2014 | 990 | 0.020 |
Why?
| | Influenza, Human | 1 | 2016 | 624 | 0.020 |
Why?
| | Biopsy | 1 | 2014 | 1082 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1300 | 0.020 |
Why?
| | Legionella | 1 | 2009 | 9 | 0.020 |
Why?
| | Mycobacterium avium | 1 | 2009 | 21 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 481 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2012 | 896 | 0.020 |
Why?
| | Boronic Acids | 1 | 1989 | 36 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2012 | 318 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 3211 | 0.020 |
Why?
| | Enzyme Precursors | 1 | 1989 | 15 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2009 | 196 | 0.020 |
Why?
| | Clinical Medicine | 1 | 2009 | 26 | 0.020 |
Why?
| | Indoles | 1 | 2013 | 507 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 1992 | 2131 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1777 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 1995 | 1482 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2021 | 3916 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 408 | 0.020 |
Why?
| | RNA | 1 | 2013 | 912 | 0.020 |
Why?
| | Washington | 1 | 2007 | 149 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1428 | 0.020 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2006 | 29 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 1000 | 0.010 |
Why?
| | Internal Medicine | 1 | 2009 | 279 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2013 | 2514 | 0.010 |
Why?
| | Pediatrics | 1 | 2014 | 1125 | 0.010 |
Why?
| | Biomedical Research | 1 | 2012 | 719 | 0.010 |
Why?
| | Amino Acids | 1 | 1989 | 519 | 0.010 |
Why?
| | Guinea Pigs | 1 | 2005 | 159 | 0.010 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2005 | 12 | 0.010 |
Why?
| | Culture Media | 1 | 2005 | 161 | 0.010 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 533 | 0.010 |
Why?
| | Apoptosis | 1 | 2013 | 2445 | 0.010 |
Why?
| | Tuberculosis, Pulmonary | 1 | 2005 | 127 | 0.010 |
Why?
| | Organ Specificity | 1 | 2005 | 309 | 0.010 |
Why?
| | Risk-Taking | 1 | 2007 | 323 | 0.010 |
Why?
| | DNA Transposable Elements | 1 | 2005 | 124 | 0.010 |
Why?
| | Protein Conformation | 2 | 2002 | 938 | 0.010 |
Why?
| | Sputum | 1 | 2005 | 302 | 0.010 |
Why?
| | Gastrostomy | 1 | 2005 | 130 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2016 | 2977 | 0.010 |
Why?
| | Psychometrics | 1 | 2007 | 732 | 0.010 |
Why?
| | Pregnancy Trimester, Second | 1 | 2002 | 85 | 0.010 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2002 | 49 | 0.010 |
Why?
| | Ambulatory Care | 1 | 2007 | 610 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2005 | 1043 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2005 | 1271 | 0.010 |
Why?
| | Practice Patterns, Physicians' | 1 | 2009 | 1372 | 0.010 |
Why?
| | Cations, Divalent | 1 | 1998 | 48 | 0.010 |
Why?
| | Hydrolysis | 1 | 1998 | 197 | 0.010 |
Why?
| | Bacillus subtilis | 1 | 1998 | 65 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 2003 | 603 | 0.010 |
Why?
| | Suppression, Genetic | 1 | 1995 | 25 | 0.010 |
Why?
| | RNA Splicing Factors | 1 | 1995 | 66 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1568 | 0.010 |
Why?
| | Mutagenesis | 1 | 1995 | 194 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2001 | 4151 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1995 | 500 | 0.010 |
Why?
| | Crystallography | 1 | 1989 | 27 | 0.000 |
Why?
| | Chemistry | 1 | 1989 | 41 | 0.000 |
Why?
| | Chemical Phenomena | 1 | 1989 | 77 | 0.000 |
Why?
| | Genes | 1 | 1989 | 228 | 0.000 |
Why?
| | Genetic Vectors | 1 | 1989 | 335 | 0.000 |
Why?
| | Recombinant Proteins | 1 | 1989 | 1368 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|